^
    CD20 positive
    CLL
    Truxima (rituximab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    CLL
    rituximab + ibrutinib
    Sensitive
    :
    A1
    Chr del(17p)
    CLL
    venetoclax + obinutuzumab
    Sensitive
    :
    A1
    TP53 mutation
    CLL
    venetoclax + obinutuzumab
    Sensitive
    :
    A1
    No biomarker
    CLL
    venetoclax + obinutuzumab
    Sensitive
    :
    A1
    No biomarker
    CLL
    ICP-022
    Sensitive
    :
    A1
    CD20 expression
    CLL
    rituximab-arrx
    Sensitive
    :
    A1
    TP53 mutation
    CLL
    venetoclax
    Sensitive
    :
    A1
    No biomarker
    CLL
    Truxima (rituximab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    CLL
    Rixathon (rituximab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    CLL
    Ruxience (rituximab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    CLL
    venetoclax + rituximab
    Sensitive
    :
    A1
    Chr del(17p)
    CLL
    venetoclax
    Sensitive
    :
    A1
    No biomarker
    CLL
    zanubrutinib
    Sensitive
    :
    A1
    No biomarker
    CLL
    ibrutinib
    Sensitive
    :
    A1
    No biomarker
    CLL
    ibrutinib + obinutuzumab
    Sensitive
    :
    A1
    No biomarker
    CLL
    obinutuzumab
    Sensitive
    :
    A1
    No biomarker
    CLL
    rituximab
    Sensitive
    :
    A1
    No biomarker
    CLL
    ofatumumab
    Sensitive
    :
    A1
    CD20 positive
    CLL
    rituximab
    Sensitive
    :
    A1
    No biomarker
    CLL
    venetoclax
    Sensitive
    :
    A1
    No biomarker
    CLL
    rituximab/hyaluronidase
    Sensitive
    :
    A1
    Chr del(17p)
    CLL
    ibrutinib
    Sensitive
    :
    A1
    No biomarker
    CLL
    obinutuzumab + acalabrutinib
    Sensitive
    :
    A1
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES